Evidence map›Paper›PMID 41207942›Full record

ArticleAdvances in experimental medicine and biology2026

Structural and Functional Characterization of Protein Adhesins and Pili in Mycobacterium tuberculosis.

Parissa Farnia, Ali Akbar Velayati, Jalaledin Ghanavi, Poopak Farnia

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parissa FarniaShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran. farnia@theaasm.org.
Ali Akbar VelayatiShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.
Jalaledin GhanaviShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.
Poopak FarniaShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) is a highly adaptable pathogen whose ability to establish infection and persist within the host is primarily driven by a diverse array of adhesins, surface proteins, and structures that mediate attachment to host cells and tissues. These adhesins play critical roles in bacterial colonization, invasion, immune evasion, and long-term persistence, making them central to Mtb pathogenesis. Mtb adhesins can be broadly categorized based on their structural features, functional roles, and binding specificities. Protein adhesins such as LpqH (the 19-kDa lipoprotein), PstS-1 (phosphate-binding protein), Cpn60.2 (chaperonin GroEL2), Apa (alanine- and proline-rich antigen), members of the PE-PGRS protein family, the antigen 85 complex (Ag85A, Ag85B, and Ag85C), glutamine synthetase A1, malate synthase, N-acetylmuramoyl-L-alanine amidase, the histone-like HU protein, protein kinase D, ESAT-6, Mce1, and HBHA (heparin-binding hemagglutinin adhesin) exhibit specific affinities for host cell receptors and extracellular matrix components such as fibronectin, laminin, and epithelial surfaces. Many of these proteins are multifunctional "moonlighting" enzymes, performing both metabolic and adhesive roles, thereby enhancing bacterial survival and virulence. In addition to protein adhesins, Mtb expresses a variety of pili and fimbrial structures that further augment its capacity to interact with the host. Recent atomic force microscopy studies have identified seven distinct pili types on the mycobacterial surface: Type III (secretion needle pili), Type IV secretion pili, Type IV-like pili, curli-like pili (MTP), and the newly described Types V (relief funnel pili), VI (adhesion tapering pili), and VII (adhesion flap pili). These pili exhibit remarkable structural diversity, with Types VI and VII found exclusively in extensively drug-resistant (XDR) and totally drug-resistant (TDR) Mtb strains, suggesting a role in adaptation to antibiotic pressure and enhanced survival. Functionally, curli-like and Type IV pili contribute to biofilm formation, bacterial aggregation, and robust adhesion to macrophages and epithelial cells, while the novel pili types (V, VI, and VII) may mediate specialized adhesion and intercellular interactions, particularly in drug-resistant isolates. The adhesins and pili target diverse host molecules: some facilitate macrophage binding (e.g., LpqH, PstS-1, Cpn60.2, Apa), others bind fibronectin and laminin (e.g., PE-PGRS proteins, antigen 85 complex, malate synthase, curli-like pili), and yet others adhere to epithelial cells (e.g., Mce1, HBHA, Type IV pili). This multifaceted adhesion strategy enables Mtb to colonize a wide range of tissue environments, evade immune defenses, and establish latent or persistent infections. The redundancy and multifunctionality of these adhesins and pili underscore their evolutionary significance in Mtb's lifecycle. Collectively, the surface adhesins and pili constitute a complex and versatile toolkit that underpins Mtb pathogenicity. The discovery of multiple distinct pili types, especially those associated with drug resistance, opens new avenues for research into bacterial adaptation, persistence, and immune evasion mechanisms. A comprehensive understanding of these structures and their interactions with host tissues holds promise for the development of innovative diagnostics, vaccines, and antiadhesin therapies aimed at combating both drug-sensitive and drug-resistant tuberculosis.

Indexed as

Adhesins, BacterialFimbriae, BacterialMycobacterium tuberculosisAnimalsBacterial AdhesionBacterial ProteinsHumansTuberculosisAdhesins, BacterialBacterial ProteinsCurli-like pili (MTP)Mycobacterium tuberculosisProtein adhesinsSecretion needle piliTypes VI (adhesion tapering pili)Types VII (adhesion flap pili)Types V (relief funnel pili)

Identifiers

PMID41207942

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.